BACKGROUND: To describe incidence rates (IR) and risk factors for loss-to-follow-up (LTFU) among HIV-infected and HIV-exposed children in a large HIV treatment programme in Western Kenya. METHODS: The USAID-AMPATH Partnership has enrolled >100,000 patients (20% children) at 23 clinic sites throughout western Kenya. LTFU is defined as being absent from the clinic for >3 months if on combination antiretroviral treatment (cART) and >6 months if not. Included in this analysis were children aged <14 years, HIV exposed or infected at enrollment, and enrolled between April 2002 and March 2009. The IR for LTFU are presented per 100 child-years (CY) of follow-up. Proportional hazards models with time-independent and time-dependent covariates were used to model factors associated with LTFU. Weight for height Z-scores were calculated using EpiInfo, with severe malnutrition being defined as a Z-score <or=-3.0. Immune suppression was defined as per WHO age-specific categories. RESULTS: There were 13,510 children eligible for analysis, comprising 3106 children who at enrollment were HIV infected and 10,404 children who were HIV exposed. The overall IR of LTFU was 18.4 (17.8-18.9) per 100 CY. Among HIV-infected children, 15.2 (13.8-16.7) and 14.1 (13.1-15.8) per 100 CY became LTFU, pre- and post-cART initiation, respectively. The only independent risk factor for becoming LTFU among the HIV-infected children was severe immune suppression (AHR: 2.17, 95% CI: 1.51-3.12). Among the HIV-exposed children, 20.1 per 100 (19.4-20.7) became LTFU. Independent risk factors for LTFU among them were being severely low weight for height (AHR: 1.69, 95% CI: 1.25-2.28), being orphaned at enrollment (AHR: 1.57, 95% CI: 1.23-1.64), being CDC Class B or C (AHR: 1.41, 95% CI: 1.14-1.74), and having received cART (AHR: 1.56, 95% CI: 1.23-1.99). Protective against becoming LTFU among the HIV exposed were testing HIV positive (AHR: 0.26, 95% CI: 0.21-0.32), older age (AHR: 0.90, 95% CI: 0.85-0.96), enrolling in later time periods, and receiving food supplementation (AHR: 0.58, 95% CI: 0.32-1.04). CONCLUSIONS: There is a high rate of LTFU among these highly vulnerable children, particularly among the HIV exposed. These data suggest that HIV-infected and HIV-exposed children are at especially high risk for LTFU if they are sick or malnourished.
BACKGROUND: To describe incidence rates (IR) and risk factors for loss-to-follow-up (LTFU) among HIV-infected and HIV-exposed children in a large HIV treatment programme in Western Kenya. METHODS: The USAID-AMPATH Partnership has enrolled >100,000 patients (20% children) at 23 clinic sites throughout western Kenya. LTFU is defined as being absent from the clinic for >3 months if on combination antiretroviral treatment (cART) and >6 months if not. Included in this analysis were children aged <14 years, HIV exposed or infected at enrollment, and enrolled between April 2002 and March 2009. The IR for LTFU are presented per 100 child-years (CY) of follow-up. Proportional hazards models with time-independent and time-dependent covariates were used to model factors associated with LTFU. Weight for height Z-scores were calculated using EpiInfo, with severe malnutrition being defined as a Z-score <or=-3.0. Immune suppression was defined as per WHO age-specific categories. RESULTS: There were 13,510 children eligible for analysis, comprising 3106 children who at enrollment were HIV infected and 10,404 children who were HIV exposed. The overall IR of LTFU was 18.4 (17.8-18.9) per 100 CY. Among HIV-infectedchildren, 15.2 (13.8-16.7) and 14.1 (13.1-15.8) per 100 CY became LTFU, pre- and post-cART initiation, respectively. The only independent risk factor for becoming LTFU among the HIV-infectedchildren was severe immune suppression (AHR: 2.17, 95% CI: 1.51-3.12). Among the HIV-exposed children, 20.1 per 100 (19.4-20.7) became LTFU. Independent risk factors for LTFU among them were being severely low weight for height (AHR: 1.69, 95% CI: 1.25-2.28), being orphaned at enrollment (AHR: 1.57, 95% CI: 1.23-1.64), being CDC Class B or C (AHR: 1.41, 95% CI: 1.14-1.74), and having received cART (AHR: 1.56, 95% CI: 1.23-1.99). Protective against becoming LTFU among the HIV exposed were testing HIV positive (AHR: 0.26, 95% CI: 0.21-0.32), older age (AHR: 0.90, 95% CI: 0.85-0.96), enrolling in later time periods, and receiving food supplementation (AHR: 0.58, 95% CI: 0.32-1.04). CONCLUSIONS: There is a high rate of LTFU among these highly vulnerable children, particularly among the HIV exposed. These data suggest that HIV-infected and HIV-exposed children are at especially high risk for LTFU if they are sick or malnourished.
Authors: Winstone M Nyandiko; Samuel Ayaya; Esther Nabakwe; Constance Tenge; John E Sidle; Constantin T Yiannoutsos; Beverly Musick; Kara Wools-Kaloustian; William M Tierney Journal: J Acquir Immune Defic Syndr Date: 2006-12-01 Impact factor: 3.731
Authors: Erik George; Francine Noël; Gyrlande Bois; Rachelle Cassagnol; Louise Estavien; Patricia De Matteis Rouzier; Rose I Verdier; Warren D Johnson; Jean W Pape; Daniel W Fitzgerald; Peter F Wright Journal: J Infect Dis Date: 2007-04-03 Impact factor: 5.226
Authors: J P Ioannidis; T E Taha; N Kumwenda; R Broadhead; L Mtimavalye; P Miotti; F Yellin; D G Contopoulos-Ioannidis; R J Biggar Journal: Int J Epidemiol Date: 1999-08 Impact factor: 7.196
Authors: N K M van Kooten Niekerk; M M Knies; J Howard; H Rabie; M Zeier; A van Rensburg; N Frans; H S Schaaf; G Fatti; F Little; M F Cotton Journal: J Trop Pediatr Date: 2005-06-09 Impact factor: 1.165
Authors: Robert M Einterz; Sylvester Kimaiyo; Haroun N K Mengech; Barasa O Khwa-Otsyula; Fabian Esamai; Fran Quigley; Joseph J Mamlin Journal: Acad Med Date: 2007-08 Impact factor: 6.893
Authors: William M Tierney; Joseph K Rotich; Terry J Hannan; Abraham M Siika; Paul G Biondich; Burke W Mamlin; Winstone M Nyandiko; Sylvester Kimaiyo; Kara Wools-Kaloustian; John E Sidle; Chrispinus Simiyu; Erika Kigotho; Beverly Musick; Joseph J Mamlin; Robert M Einterz Journal: Stud Health Technol Inform Date: 2007
Authors: Margaret May; Jonathan A C Sterne; Caroline Sabin; Dominique Costagliola; Amy C Justice; Rodolphe Thiébaut; John Gill; Andrew Phillips; Peter Reiss; Robert Hogg; Bruno Ledergerber; Antonella D'Arminio Monforte; Norbert Schmeisser; Shlomo Staszewski; Matthias Egger Journal: AIDS Date: 2007-05-31 Impact factor: 4.177
Authors: Monique van Lettow; Richard Bedell; Megan Landes; Lucy Gawa; Stephanie Gatto; Isabell Mayuni; Adrienne K Chan; Lyson Tenthani; Erik Schouten Journal: BMC Public Health Date: 2011-06-03 Impact factor: 3.295
Authors: Edwin Masese Machine; Susan L Gillespie; Nuria Homedes; Beatrice J Selwyn; Michael W Ross; Gabriel Anabwani; Gordon Schutze; Mark W Kline Journal: AIDS Care Date: 2016-05-10
Authors: Carolyn M Audet; Meridith Blevins; Yazalde Manuel Chire; Muktar H Aliyu; Lara M E Vaz; Elisio Antonio; Fernanda Alvim; Ruth Bechtel; C William Wester; Sten H Vermund Journal: AIDS Behav Date: 2016-09
Authors: Njoroge Anne; Matthew D Dunbar; Felix Abuna; Peter Simpson; Paul Macharia; Bourke Betz; Peter Cherutich; David Bukusi; Farquhar Carey Journal: Int J Med Inform Date: 2019-10-18 Impact factor: 4.046
Authors: Eric D McCollum; Geoffrey A Preidis; Carrie L Golitko; Linias D Siwande; Charles Mwansambo; Peter N Kazembe; Irving Hoffman; Mina C Hosseinipour; Gordon E Schutze; Mark W Kline Journal: Pediatr Infect Dis J Date: 2011-05 Impact factor: 2.129
Authors: Peter F Rebeiro; Giorgos Bakoyannis; Beverly S Musick; Ronald S Braithwaite; Kara K Wools-Kaloustian; Winstone Nyandiko; Fatma Some; Paula Braitstein; Constantin T Yiannoutsos Journal: J Acquir Immune Defic Syndr Date: 2017-10-01 Impact factor: 3.731
Authors: Lydia Feinstein; Andrew Edmonds; Jean Lambert Chalachala; Vitus Okitolonda; Jean Lusiama; Annelies Van Rie; Benjamin H Chi; Stephen R Cole; Frieda Behets Journal: AIDS Date: 2014-07 Impact factor: 4.177
Authors: B Ryan Phelps; Saeed Ahmed; Anouk Amzel; Mamadou O Diallo; Troy Jacobs; Scott E Kellerman; Maria H Kim; Nandita Sugandhi; Melanie Tam; Megan Wilson-Jones Journal: AIDS Date: 2013-11 Impact factor: 4.177
Authors: Nora M McCormick; Nan Li; David Sando; Aisa Muya; Karim P Manji; Rodrick Kisenge; Christopher Duggan; Guerino Chalamilla; Wafaie W Fawzi; Donna Spiegelman Journal: J Acquir Immune Defic Syndr Date: 2015-11-01 Impact factor: 3.731